A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
A study from Columbia University researchers suggests that DNA sequencing can help diagnose the underlying genetic causes of fetal anomalies found during prenatal ultrasounds.
Columbia scientists are using CRISPR to create stem cells that could ultimately alleviate diabetes in rare neonatal cases and may lead to a cell therapy for more common forms of the disease.
Columbia researchers have discovered that the human intestine has a reservoir of blood-forming stem cells and that the cells play a central role in the success of organ transplantation.
Increasingly, transformative therapies are being launched via startups emerging from university research labs, including those at Columbia’s Vagelos College of Physicians and Surgeons.